相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
C. Baigent et al.
AMERICAN HEART JOURNAL (2010)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey
Zeljko Reiner et al.
ATHEROSCLEROSIS (2010)
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
Eric Bruckert et al.
ATHEROSCLEROSIS (2010)
Cardiovascular Risk-Estimation Systems in Primary Prevention Do They Differ? Do They Make a Difference? Can We See the Future?
Marie Therese Cooney et al.
CIRCULATION (2010)
Colesevelam Added to Combination Therapy With a Statin and Ezetimibe in Patients With Familial Hypercholesterolemia: A 12-Week, Multicenter, Randomized, Double-Blind, Controlled Trial
Roeland Huijgen et al.
CLINICAL THERAPEUTICS (2010)
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
Vivian A. Fonseca et al.
DIABETES OBESITY & METABOLISM (2010)
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes
M. -R. Taskinen et al.
DIABETOLOGIA (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Combined therapy in the treatment of dyslipidemia
Zeljko Reiner
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2010)
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
Mario Petretta et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus - A pooled meta-analysis of randomized placebo-controlled clinical trials
Sandeep A. Saha et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
Klas Gransbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis) Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration
Todd C. Villines et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Metabolic Syndrome and Cardiovascular Risk A Systematic Review and Meta-Analysis
Salvatore Mottillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2010)
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
LANCET (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Min Jun et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Paul W. Ladenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Daan Kromhout et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
M. John Chapman et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Public perceptions of cardiovascular risk factors in Croatia The PERCRO survey
Zeljko Reiner et al.
PREVENTIVE MEDICINE (2010)
Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patients
R. A. Whittall et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
Xue-Qiao Zhao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention
Jose M. Ordovas
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients A Randomized Trial
David J. Becker et al.
ANNALS OF INTERNAL MEDICINE (2009)
Cardiovascular morbidity in psoriatic arthritis
D. D. Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease
Andrew Mente et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate
Marja-Riitta Taskinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins
Cesare R. Sirtori et al.
ATHEROSCLEROSIS (2009)
HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk
M. T. Cooney et al.
ATHEROSCLEROSIS (2009)
Omega-6 Fatty Acids and Risk for Cardiovascular Disease A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention
William S. Harris et al.
CIRCULATION (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Targets of Statin Therapy: LDL Cholesterol, Non-HDL Cholesterol, and Apoliproprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)
Valentine Charlton-Menys et al.
CLINICAL CHEMISTRY (2009)
Perspectives on low-density lipoprotein cholesterol goal achievement
Alberico L. Catapano
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Severe hypertriglyceridemia and pancreatitis: presentation and management
Nils Ewald et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Russell Scott et al.
DIABETES CARE (2009)
Combination statin-fibrate therapy: safety aspects
R. Franssen et al.
DIABETES OBESITY & METABOLISM (2009)
Treatment of Acute Myocardial Infarction in Patients with Stimulant ST-segment Elevation
Frans Van de Werf et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators
Marie Therese Cooney et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
Dinanda J. de Jager et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial
Germano Di Sciascio et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk A Review for Clinicians
Marie Therese Cooney et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Contraceptive Hormone Use and Cardiovascular Disease
Chrisandra L. Shufelt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
Jennifer G. Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
Justin M. S. Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M. Ridker et al.
LANCET (2009)
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Pierre Amarenco et al.
LANCET NEUROLOGY (2009)
Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery.
Olaf Schouten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Efficacy and Tolerability of Ezetimibe in Cardiac Transplant Recipients Taking Cyclosporin
Steven M. Shaw et al.
TRANSPLANTATION (2009)
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
J. J. Brugts et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Effect of Xuezhikang, an extract from red yeast chinese rice, on coronary events in a Chinese population with previous myocardial infarction
Zongliang Lu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk
B. Greg Brown et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Relative safety of Gemfibrozil and Fenofibrate in the absence of concomitant Cerivastatin use
Noa Holoshitz et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Mechanism of action of niacin
Vaijinath S. Kamanna et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia
Jean-Charles Fruchart et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Lowering LDL cholesterol in adults: A prospective, community-based practice initiative
Gregg O. Coodley et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
Ingar Holme et al.
ANNALS OF MEDICINE (2008)
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
Martin Adiels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
Yasushi Saito et al.
ATHEROSCLEROSIS (2008)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Fasting and Nonfasting Lipid Levels Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction
Anne Langsted et al.
CIRCULATION (2008)
Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy
David A. Wohl et al.
CLINICAL INFECTIOUS DISEASES (2008)
Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study
Pirjo Ilanne-Parikka et al.
DIABETES CARE (2008)
Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
Andrew Neil et al.
EUROPEAN HEART JOURNAL (2008)
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV
J. D. Lundgren et al.
HIV MEDICINE (2008)
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia
John R. Guyton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Characteristics of the diet patterns tested in the Optimal Macronutrient Intake Trial to Prevent Heart Disease (OmniHeart): Options for a heart-healthy diet
Janis F. Swain et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2008)
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
D. A. Wood et al.
LANCET (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
Anne B. Rossebo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Non-pharmacological control of plasma cholesterol levels
Andrea Poli et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
The safety of rosuvastatin in comparison with other statins in over 100 000 statin users in UK primary care
Luis Alberto Garcia-Rodriguez et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation
Frans Van de Werf et al.
EUROPEAN HEART JOURNAL (2008)
Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities
Todd C. Rideout et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and pravastatin or atorvastatin evaluation and infection therapy - Thrombolysis in myocardial infarction 22 trials)
Sabina A. Murphy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Philip Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk
F. Drenos et al.
ANNALS OF HUMAN GENETICS (2007)
Diabetes and mortality following acute coronary syndromes
Sean M. Donahoe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Statins: An essential component in the management of carotid artery disease
Kosmas I. Paraskevas et al.
JOURNAL OF VASCULAR SURGERY (2007)
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Sandeep Bansal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European society of cardiology
Jean-Pierre Bassand et al.
EUROPEAN HEART JOURNAL (2007)
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
Michael H. Davidson et al.
CLINICAL THERAPEUTICS (2007)
Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome
Jing Liu et al.
AMERICAN HEART JOURNAL (2007)
Safety considerations with fibrate therapy
Michael H. Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Safety considerations with niacin therapy
John R. Guyton et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER study)
Christie M. Ballantyne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effect of high-dose atorvastatin on hospitalizations for heart failure - Subgroup analysis of the treating to new targets (TNT) study
Kiran K. Khush et al.
CIRCULATION (2007)
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Marina Cuchel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
Jeppe N. Rasmussen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Alcohol consumption and risk for coronary heart disease among men with hypertension
Joline W. J. Beulens et al.
ANNALS OF INTERNAL MEDICINE (2007)
The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment
Amanda D. Hyre et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
European guidelines on cardiovascular disease prevention in clinical practice: Full text
Ian Graham et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2007)
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
S. E. Humphries et al.
JOURNAL OF MEDICAL GENETICS (2006)
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
T. R. Glass et al.
HIV MEDICINE (2006)
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
Chris J. Packard
CURRENT OPINION IN LIPIDOLOGY (2006)
Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme
L. J. Lea et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
Statins for improving renal outcomes: A meta-analysis
Sabrina Sandhu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study
BM Scirica et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia - A randomized controlled trial
HK Berthold et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Statin safety: An assessment using an administrative claims database
MJ Cziraky et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force
JM McKenney et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
L Hooper et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Clinical review: A critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations
A Dewell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors - A meta-analysis of randomized controlled trials
AJ Nordmann et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Low-fat dietary pattern and risk of cardiovascular disease - The Women's Health Initiative randomized controlled dietary modification trial
BV Howard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels
AD Mooradian et al.
ENDOCRINE REVIEWS (2006)
Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?
K. I. Paraskevas et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2006)
Effect of pravastatin in people with diabetes and chronic kidney disease
M Tonelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial
TR Pedersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes
KK Ray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease
E Tedeschi-Reiner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PASSCLAIM -: Consensus on criteria
PJ Aggett et al.
EUROPEAN JOURNAL OF NUTRITION (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (The SAFARI Trial)
SM Grundy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Drug therapy in the heart transplant recipient - Part IV: Drug-drug interactions
RL Page et al.
CIRCULATION (2005)
Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the coronary drug project)
PL Canner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Reporting rate of Rhabdomyolysis with fenofibrate plus statin versus gemfibrozil plus any statin
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial
AES Durazzo et al.
JOURNAL OF VASCULAR SURGERY (2004)
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial
JA de Lemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis
P Amarenco et al.
STROKE (2004)
Drug treatment of hyperlipidemia in women
JME Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Effect of statins on the progression of bioprosthetic aortic valve degeneration
F Antonini-Canterin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease
MM McDermott et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus
CM Thorburn et al.
ARTHRITIS AND RHEUMATISM (2003)
Estrogen plus progestin and the risk of coronary heart disease
JE Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
MR Law et al.
BRITISH MEDICAL JOURNAL (2003)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
H Holdaas et al.
LANCET (2003)
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
SP Laing et al.
DIABETOLOGIA (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Optimal diets for prevention of coronary heart disease
FB Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Effects of the amount and intensity of exercise on plasma lipoproteins
WE Kraus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention - A randomized controlled trial
PWJC Serruys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction - Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
R Marchioli et al.
CIRCULATION (2002)
Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men?: The Reykjavik Study
LS Jónsdóttir et al.
JOURNAL OF CARDIOVASCULAR RISK (2002)
Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families - Results of a 5-year follow-up study
MJ Veerkamp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S
CM Ballantyne et al.
CIRCULATION (2001)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
BG Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
GG Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease - The bezafibrate infarction prevention (BIP) study
Z Schlesinger et al.
CIRCULATION (2000)
Selecting target conditions for quality of care improvement in vulnerable older adults
EM Sloss et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2000)
分享论文
